Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (83)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kurose, K.
Right arrow Articles by Eng, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurose, K.
Right arrow Articles by Eng, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 18 1907-1913
© 2001 Oxford University Press

Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour–microenvironment interactions

Keisuke Kurose1,2, Stacy Hoshaw-Woodard3, Adewale Adeyinka4, Stanley Lemeshow3, Peter H. Watson4 and Charis Eng1,2,5,+

1Clinical Cancer Genetics and Human Cancer Genetics Programs, Comprehensive Cancer Centre, and Division of Human Genetics, Department of Internal Medicine, 2Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics and 3Center for Biostatistics, Comprehensive Cancer Centre, The Ohio State University, Columbus, OH 43210, USA, 4Department of Pathology, University of Manitoba Health Sciences Centre, Winnipeg, Manitoba R3E 0W3, Canada and 5CRC Human Cancer Genetics Research Group, University of Cambridge, Cambridge CB2 2QQ, UK

Although numerous studies have reported that high frequencies of loss of heterozygosity (LOH) at various chromosomal arms have been identified in breast cancer, differential LOH in the neoplastic epithelial and surrounding stromal compartments has not been well examined. Using laser capture microdissection, which enables separation of neoplastic epithelium from surrounding stroma, we microdissected each compartment of 41 sporadic invasive adenocarcinomas of the breast. Frequent LOH was identified in both neoplastic epithelial and/or stromal compartments, ranging from 25 to 69% in the neoplastic epithelial cells, and from 17 to 61% in the surrounding stromal cells, respectively. The great majority of markers showed a higher frequency of LOH in the neoplastic epithelial compartment than in the stroma, suggesting that LOH in neoplastic epithelial cells might precede LOH in surrounding stromal cells. Furthermore, we sought to examine pair-wise associations of particular genetic alterations in either epithelial or stromal compartments. Seventeen pairs of markers showed statistically significant associations. We also propose a genetic model of multi-step carcinogenesis for the breast involving the epithelial and stromal compartments and note that genetic alterations occur in the epithelial compartments as the earlier steps followed by LOH in the stromal compartments. Our study strongly suggests that interactions between breast epithelial and stromal compartments might play a critical role in breast carcinogenesis and several genetic alterations in both epithelial and stromal compartments are required for breast tumour growth and progression.

+ To whom correspondence should be addressed at: Human Cancer Genetics Program, The Ohio State University Comprehensive Cancer Centre, 420 West 12th Avenue, Room 690C TMRF, Columbus, OH 43210, USA. Tel: +1 614 292 2347; Fax: +1 614 688 3582; Email: eng-1{at}medctr.osu.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. Eng, G. Leone, M. S. Orloff, and M. C. Ostrowski
Genomic Alterations in Tumor Stroma
Cancer Res., September 1, 2009; 69(17): 6759 - 6764.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-Q. Xiong, H.-C. Sun, W. Zhang, X.-D. Zhu, P.-Y. Zhuang, J.-B. Zhang, L. Wang, W.-z. Wu, L.-X. Qin, and Z.-Y. Tang
Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Clin. Cancer Res., August 1, 2009; 15(15): 4838 - 4846.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. M. Eck, A. L. Cote, W. D. Winkelman, and C. E. Brinckerhoff
CXCR4 and Matrix Metalloproteinase-1 Are Elevated in Breast Carcinoma-Associated Fibroblasts and in Normal Mammary Fibroblasts Exposed to Factors Secreted by Breast Cancer Cells
Mol. Cancer Res., July 1, 2009; 7(7): 1033 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. W. Studebaker, G. Storci, J. L. Werbeck, P. Sansone, A. K. Sasser, S. Tavolari, T. Huang, M. W.Y. Chan, F. C. Marini, T. J. Rosol, et al.
Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6-Dependent Manner
Cancer Res., November 1, 2008; 68(21): 9087 - 9095.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Assie, T. LaFramboise, P. Platzer, and C. Eng
Frequency of Germline Genomic Homozygosity Associated With Cancer Cases
JAMA, March 26, 2008; 299(12): 1437 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Trimboli, K. Fukino, A. de Bruin, G. Wei, L. Shen, S. M. Tanner, N. Creasap, T. J. Rosol, M. L. Robinson, C. Eng, et al.
Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer
Cancer Res., February 1, 2008; 68(3): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Patocs, L. Zhang, Y. Xu, F. Weber, T. Caldes, G. L. Mutter, P. Platzer, and C. Eng
Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
N. Engl. J. Med., December 20, 2007; 357(25): 2543 - 2551.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. K. Sasser, N. J. Sullivan, A. W. Studebaker, L. F. Hendey, A. E. Axel, and B. M. Hall
Interleukin-6 is a potent growth factor for ER-{alpha}-positive human breast cancer
FASEB J, November 1, 2007; 21(13): 3763 - 3770.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. Fukino, L. Shen, A. Patocs, G. L. Mutter, and C. Eng
Genomic Instability Within Tumor Stroma and Clinicopathological Characteristics of Sporadic Primary Invasive Breast Carcinoma
JAMA, May 16, 2007; 297(19): 2103 - 2111.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Sadlonova, S. Mukherjee, D. B. Bowe, S. R. Gault, N. A. Dumas, B. A. Van Tine, N. Frolova, G. P. Page, D. R. Welch, L. Novak, et al.
Human Breast Fibroblasts Inhibit Growth of the MCF10AT Xenograft Model of Proliferative Breast Disease
Am. J. Pathol., March 1, 2007; 170(3): 1064 - 1076.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. Weber, Y. Xu, L. Zhang, A. Patocs, L. Shen, P. Platzer, and C. Eng
Microenvironmental Genomic Alterations and Clinicopathological Behavior in Head and Neck Squamous Cell Carcinoma
JAMA, January 10, 2007; 297(2): 187 - 195.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. S. Yan, C. Venkataramu, A. Ibrahim, J. C. Liu, R. Z. Shen, N. M. Diaz, B. Centeno, F. Weber, Y.-W. Leu, C. L. Shapiro, et al.
Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue.
Clin. Cancer Res., November 15, 2006; 12(22): 6626 - 6636.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. J. Fabian and B. F. Kimler
Mammographic Density: Use in Risk Assessment and as a Biomarker in Prevention Trials
J. Nutr., October 1, 2006; 136(10): 2705S - 2708S.
[Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kiaris, I. Chatzistamou, G. Trimis, M. Frangou-Plemmenou, A. Pafiti-Kondi, and A. Kalofoutis
Evidence for Nonautonomous Effect of p53 Tumor Suppressor in Carcinogenesis
Cancer Res., March 1, 2005; 65(5): 1627 - 1630.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Weber, M. A. Aldred, C. D. Morrison, C. Plass, A. Frilling, C. E. Broelsch, K. A. Waite, and C. Eng
Silencing of the Maternally Imprinted Tumor Suppressor ARHI Contributes to Follicular Thyroid Carcinogenesis
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1149 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M.J. BISSELL, P.A. KENNY, and D.C. RADISKY
Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression: The Role of Extracellular Matrix and Its Degrading Enzymes
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 343 - 356.
[Abstract] [PDF]


Home page
Cancer Res.Home page
K. Fukino, L. Shen, S. Matsumoto, C. D. Morrison, G. L. Mutter, and C. Eng
Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets
Cancer Res., October 15, 2004; 64(20): 7231 - 7236.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
E. Sivridis, A. Giatromanolaki, and M. I. Koukourakis
"Stromatogenesis" and Tumor Progression
International Journal of Surgical Pathology, January 1, 2004; 12(1): 1 - 9.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
K. Okudela, H. Hayashi, T. Ito, T. Yazawa, T. Suzuki, Y. Nakane, H. Sato, H. Ishi, X. KeQin, A. Masuda, et al.
K-ras Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells via Akt Activation: Possible Contribution to Non-Invasive Expansion of Lung Adenocarcinoma
Am. J. Pathol., January 1, 2004; 164(1): 91 - 100.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Matsumoto, T. Yoshida, and I. Okayasu
High Epithelial and Stromal Genetic Instability of Chromosome 17 in Ulcerative Colitis-associated Carcinogenesis
Cancer Res., October 1, 2003; 63(19): 6158 - 6161.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. W. Brandli, T. M. Ulbright, R. S. Foster, O. W. Cummings, S. Zhang, C. J. Sweeney, J. N. Eble, and L. Cheng
Stroma Adjacent to Metastatic Mature Teratoma after Chemotherapy for Testicular Germ Cell Tumors Is Derived from the Same Progenitor Cells as the Teratoma
Cancer Res., September 15, 2003; 63(18): 6063 - 6068.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. E. Ellsworth, D. L. Ellsworth, S. M. Lubert, J. Hooke, R. I. Somiari, and C. D. Shriver
High-Throughput Loss of Heterozygosity Mapping in 26 Commonly Deleted Regions in Breast Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 915 - 919.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H Chauhan, A Abraham, J R A Phillips, J H Pringle, R A Walker, and J L Jones
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions
J. Clin. Pathol., April 1, 2003; 56(4): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. S. Larson, A. de las Morenas, S. R. Bennett, L. A. Cupples, and C. L. Rosenberg
Loss of Heterozygosity or Allele Imbalance in Histologically Normal Breast Epithelium Is Distinct from Loss of Heterozygosity or Allele Imbalance in Co-Existing Carcinomas
Am. J. Pathol., July 1, 2002; 161(1): 283 - 290.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.